1. Overexpression of collagen type V α1 chain in human breast invasive ductal carcinoma is mediated by TGF-β1
   Weimin Ren et al, 2018, International Journal of Oncology CrossRef
2. Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer
   Min Cheng et al, 2018, Oncology Letters CrossRef
3. NAD Metabolism in Cancer Therapeutics
   Keisuke Yaku et al, 2018, Frontiers in Oncology CrossRef
4. Retracted: Effects of RNA interference‐mediated silencing of toll‐like receptor 4 gene on proliferation and apoptosis of human breast cancer MCF‐7 and MDA‐MB‐231 cells: An in vitro study
   Xiao‐Ling Gao et al, 2019, Journal of Cellular Physiology CrossRef
5. Identification of specific pre-analytical quality control markers in plasma and serum samples
   Luz Ruiz-Godoy et al, 2019, Analytical Methods CrossRef
6. Visfatin-induced upregulation of lipogenesis via EGFR/AKT/GSK3β pathway promotes breast cancer cell growth
   Pradeep Kumar Rajput et al, 2023, Cellular Signalling CrossRef
7. Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review
   Kareena Moar et al, 2023, Pathology - Research and Practice CrossRef
8. Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy
   Naveen Singh et al, 2020, Cancers CrossRef
9. Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
   Christine M. Heske, 2020, Frontiers in Oncology CrossRef
10. Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer
    Yang-Kun Wang et al, 2018, Cancer Biomarkers CrossRef
11. Prognostic value of visfatin in various human malignancies: A systematic review and meta-analysis
    Masoumeh Mohammadi et al, 2020, Cytokine CrossRef
12. Exploring the multifaceted role of obesity in breast cancer progression
    Sooraj Kakkat et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
13. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
    Cristina Travelli et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
14. The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges
    Maria Dalamaga et al, 2018, Metabolism CrossRef
15. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells
    Zafar Gholinejad et al, 2017, Peptides CrossRef
16. Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis
    Jing Liu et al, 2022, Breast Cancer: Targets and Therapy CrossRef
17. Comparison of visfatin levels in patients with breast cancer and endometrial cancer with healthy individuals: A systematic review and meta‐analysis
    Hori Ghaneialvar et al, 2022, Health Science Reports CrossRef
18. Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
    Gulden Menderes et al, 2017, Medical Oncology CrossRef
19. SPR platform based on image acquisition for HER2 antigen detection
    Johny P Monteiro et al, 2017, Nanotechnology CrossRef
20. Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential
    Yen-Yun Wang et al, 2021, Cancer Letters CrossRef
21. High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratification
    Alexandre Luiz Korte Azevedo et al, 2023, Journal of Proteomics CrossRef
22. NAD+ salvage pathway in cancer metabolism and therapy
    Barry E. Kennedy et al, 2016, Pharmacological Research CrossRef
23. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells
    Zahra Hesari et al, 2018, Gene CrossRef
24. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
    Simone Torretta et al, 2020, Cells CrossRef
25. Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Marianne Nordlund Broughton et al, 2017, Tumor Biology CrossRef
26. Autophagy in ischemic stroke
    Pei Wang et al, 2018, Progress in Neurobiology CrossRef
27. Advances in NAD-Lowering Agents for Cancer Treatment
    Moustafa S. Ghanem et al, 2021, Nutrients CrossRef